BRIMOTO SYP
MRP: 2
Packaging: 100ml
Pack Type: syrup
Composition:
Brivaracetam (10mg/ml)
Indication:
for the treatment of partial-onset (focal) seizures in patients with epilepsy, as monotherapy or adjunctive therapy.
Description:
Brivaracetam is an antiepileptic drug (AED) used as adjunctive therapy for the treatment of partial-onset (focal) seizures in patients with epilepsy. It is a high-affinity synaptic vesicle protein 2A (SV2A) ligand, which helps reduce abnormal electrical activity in the brain. Brivaracetam oral solution provides a convenient dosing option for patients who have difficulty swallowing tablets, including pediatric and elderly populations.
Strength: 10 mg/ml
Dosage Form: Oral Solution
Therapeutic Class: Antiepileptic / Anticonvulsant
Tags:
- Effective control of partial-onset seizures
- High oral bioavailability and rapid brain penetration
- Convenient liquid form for children and elderly
- Well-tolerated with predictable pharmacokinetics
- Can be used alongside other antiepileptic drugs
Usage Information
Dosage
Typical starting dose: 1 mg/kg twice daily (or as advised by physician) Maximum dose: Usually not more than 200 mg/day Administer using an oral syringe or calibrated dropper Shake well before use Follow the doctor’s exact dosing schedule — do not stop abruptly
Side Effects
Drowsiness, dizziness, fatigue Nausea, vomiting Irritability or mood changes Coordination problems Rare: Allergic reactions, suicidal thoughts Seek medical attention if severe reactions or behavioral changes occur.
Contraindications
Known hypersensitivity to Brivaracetam or any of its excipients Severe hepatic impairment (dose adjustment required — use with caution) Use during pregnancy or breastfeeding only if clearly needed and prescribed Not to be used without medical supervision in patients with psychiatric disorders or substance abuse history